A pan-cancer analysis investigating the impact of GSDMD on prognosis in kidney renal clear cell carcinoma, rectum adenocarcinoma, skin cutaneous melanoma, adrenocortical carcinoma, and liver hepatocellular carcinoma has revealed that GSDMD may play different roles at different stages of tumor development. The gene discussed is GSDMD; the disease is cancer.